Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - Euronext Paris - Matif - FR0000131757 - Common Stock - Currency: EUR

47.4  -0.86 (-1.78%)

Fundamental Rating

2

Overall ERA gets a fundamental rating of 2 out of 10. We evaluated ERA against 37 industry peers in the Metals & Mining industry. ERA has a bad profitability rating. Also its financial health evaluation is rather negative. ERA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ERA was profitable.
In the past year ERA has reported a negative cash flow from operations.
ERA had positive earnings in 4 of the past 5 years.
ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA's Return On Assets of 0.22% is on the low side compared to the rest of the industry. ERA is outperformed by 65.71% of its industry peers.
With a Return On Equity value of 0.97%, ERA is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
ERA has a Return On Invested Capital of 1.39%. This is in the lower half of the industry: ERA underperforms 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ERA is in line with the industry average of 7.32%.
The 3 year average ROIC (7.61%) for ERA is well above the current ROIC(1.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROIC 1.39%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA's Profit Margin of 0.48% is on the low side compared to the rest of the industry. ERA is outperformed by 65.71% of its industry peers.
In the last couple of years the Profit Margin of ERA has declined.
With a Operating Margin value of 3.27%, ERA is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ERA has declined.
Looking at the Gross Margin, with a value of 66.89%, ERA belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
In the last couple of years the Gross Margin of ERA has grown nicely.
Industry RankSector Rank
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ERA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
Compared to 5 years ago, ERA has more shares outstanding
Compared to 1 year ago, ERA has an improved debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ERA has an Altman-Z score of 1.13. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
ERA's Altman-Z score of 1.13 is on the low side compared to the rest of the industry. ERA is outperformed by 80.00% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that ERA has dependencies on debt financing.
With a Debt to Equity ratio value of 1.35, ERA is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC0.15
WACC9.13%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

ERA has a Current Ratio of 1.64. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
ERA has a Current ratio of 1.64. This is in the lower half of the industry: ERA underperforms 60.00% of its industry peers.
ERA has a Quick Ratio of 1.17. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.17, ERA is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.17
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.47%.
Measured over the past years, ERA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.00% on average per year.
Looking at the last year, ERA shows a decrease in Revenue. The Revenue has decreased by -9.78% in the last year.
The Revenue has been decreasing by -4.39% on average over the past years.
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%

3.2 Future

Based on estimates for the next years, ERA will show a very strong growth in Earnings Per Share. The EPS will grow by 31.30% on average per year.
Based on estimates for the next years, ERA will show a small growth in Revenue. The Revenue will grow by 5.55% on average per year.
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue Next Year5.37%
Revenue Next 2Y8.73%
Revenue Next 3Y5.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 110.23, the valuation of ERA can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ERA indicates a slightly more expensive valuation: ERA is more expensive than 68.57% of the companies listed in the same industry.
ERA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.45.
With a Price/Forward Earnings ratio of 26.74, ERA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ERA indicates a slightly more expensive valuation: ERA is more expensive than 71.43% of the companies listed in the same industry.
ERA is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 110.23
Fwd PE 26.74
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

ERA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.41
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

ERA's earnings are expected to grow with 31.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.24%
EPS Next 3Y31.3%

More info and screens

2

5. Dividend

5.1 Amount

ERA has a Yearly Dividend Yield of 2.80%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.16, ERA pays a bit more dividend than its industry peers.
ERA's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

307.14% of the earnings are spent on dividend by ERA. This is not a sustainable payout ratio.
DP307.14%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
ERA.PA Dividend Payout.ERA.PA Dividend Payout, showing the Payout Ratio.ERA.PA Dividend Payout.PayoutRetained Earnings

More info and screens

ERAMET

EPA:ERA (7/4/2025, 7:00:00 PM)

47.4

-0.86 (-1.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-30 2025-07-30
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.36B
Analysts55
Price Target61.03 (28.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP307.14%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.28%
PT rev (3m)-28.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-39.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 110.23
Fwd PE 26.74
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1.36
EV/EBITDA 9.41
EPS(TTM)0.43
EY0.91%
EPS(NY)1.77
Fwd EY3.74%
FCF(TTM)-28.23
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS101.98
BVpS50.1
TBVpS34.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROCE 1.92%
ROIC 1.39%
ROICexc 1.7%
ROICexgc 1.9%
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 454.97%
Cap/Sales 23.42%
Interest Coverage 0.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.17
Altman-Z 1.13
F-Score2
WACC9.13%
ROIC/WACC0.15
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%
Revenue Next Year5.37%
Revenue Next 2Y8.73%
Revenue Next 3Y5.55%
Revenue Next 5YN/A
EBIT growth 1Y-23.81%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year104.71%
EBIT Next 3Y37.27%
EBIT Next 5YN/A
FCF growth 1Y-61.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.27%
OCF growth 3YN/A
OCF growth 5YN/A